World Health Organization‐defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib|American Journal of Hematology|2019Cited by 191
World Health Organization‐defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib|American Journal of Hematology|2021Cited by 172
Chronic Myeloid Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in OncologyNeil P. Shah, Kristina M. Gregory, Ravi Bhatia et al.|Journal of the National Comprehensive Cancer Network|2024Cited by 116
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and managementWilliam Shomali, Jason Gotlib|American Journal of Hematology|2024Cited by 86
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Robyn M. Scherber, Stéphane Barète et al.|NEJM Evidence|2023Cited by 74